These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 8128525

  • 1. Effect of nilvadipine on the development of neurological deficits in stroke-prone spontaneously hypertensive rats.
    Takakura S, Furuichi Y, Yamamoto T, Ogawa T, Satoh H, Mori J.
    Stroke; 1994 Mar; 25(3):677-82; discussion 682-3. PubMed ID: 8128525
    [Abstract] [Full Text] [Related]

  • 2. Protective effect of nilvadipine on focal cerebral ischemia in spontaneously hypertensive rats.
    Kawamura S, Li Y, Shirasawa M, Yasui N, Fukasawa H.
    Neurol Med Chir (Tokyo); 1996 Mar; 36(3):151-5. PubMed ID: 8869150
    [Abstract] [Full Text] [Related]

  • 3. Effects of two calcium channel blockers on messenger RNA expression of endothelin-1 and nitric oxide synthase in cardiovascular tissue of hypertensive rats.
    Naruse M, Tanabe A, Seki T, Adachi C, Yoshimoto T, Mishina N, Imaki T, Naruse K, Demura R, Demura H.
    J Hypertens; 1999 Jan; 17(1):53-60. PubMed ID: 10100094
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of treatment with nilvadipine on cerebral ischemia in rats.
    Kawamura S, Li Y, Shirasawa M, Yasui N, Fukasawa H.
    Tohoku J Exp Med; 1998 Aug; 185(4):239-46. PubMed ID: 9865470
    [Abstract] [Full Text] [Related]

  • 6. Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats.
    Vacher E, Richer C, Fornes P, Clozel JP, Giudicelli.
    J Cardiovasc Pharmacol; 1996 May; 27(5):686-94. PubMed ID: 8859939
    [Abstract] [Full Text] [Related]

  • 7. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M, Koibuchi Y, Sakai S, Tsujioka K, Fujiwara T, Ozaki T, Maeda K, Motoyama I, Horiai H, Ono T.
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of MPC-1304, a novel calcium antagonist, on stroke-prone spontaneously hypertensive rats.
    Niwa M, Shigematsu K, Maeda T, Fujimoto M, Yamashita K, Kataoka Y, Taniyama K.
    Arch Int Pharmacodyn Ther; 1994 Nov; 327(3):309-29. PubMed ID: 7848014
    [Abstract] [Full Text] [Related]

  • 12. Therapeutic effects of a calcium antagonist, lacidipine, on stroke-prone spontaneously hypertensive rats with cerebrovascular lesions.
    Funato H, Watanabe M, Uemura A.
    Jpn J Pharmacol; 1999 Jul; 80(3):199-208. PubMed ID: 10461764
    [Abstract] [Full Text] [Related]

  • 13. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
    Matsubara M, Akizuki O, Ikeda J, Saeki K, Yao K, Sasaki K.
    Eur J Pharmacol; 2008 Feb 02; 580(1-2):201-13. PubMed ID: 18048030
    [Abstract] [Full Text] [Related]

  • 14. Prevention of salt-dependent cardiac remodeling and enhanced gene expression in stroke-prone hypertensive rats by the long-acting calcium channel blocker lacidipine.
    Kyselovic J, Morel N, Wibo M, Godfraind T.
    J Hypertens; 1998 Oct 02; 16(10):1515-22. PubMed ID: 9814624
    [Abstract] [Full Text] [Related]

  • 15. Nilvadipine: profile of a new calcium antagonist. An overview.
    Rosenthal J.
    J Cardiovasc Pharmacol; 1994 Oct 02; 24 Suppl 2():S92-107. PubMed ID: 7898101
    [Abstract] [Full Text] [Related]

  • 16. Effects of nilvadipine, a new calcium entry blocker, on systemic blood pressure, cardiac hypertrophy and venous distensibility in spontaneously hypertensive rats.
    Ohtsuka M, Sakai S, Miura S, Kurosaki M, Koibuchi Y, Ono T, Shibayama F.
    Arch Int Pharmacodyn Ther; 1989 Oct 02; 301():228-45. PubMed ID: 2533860
    [Abstract] [Full Text] [Related]

  • 17. Partial protection from salt-induced stroke and mortality by high oral calcium in hypertensive rats.
    Peuler JD, Schelper RL.
    Stroke; 1992 Apr 02; 23(4):532-8. PubMed ID: 1561685
    [Abstract] [Full Text] [Related]

  • 18. Nilvadipine, a new calcium channel blocker, reduces ischemic brain injury in rats.
    Takakura S, Susumu T, Satoh H, Mori J, Shiino A, Handa J.
    Jpn J Pharmacol; 1991 Aug 02; 56(4):547-50. PubMed ID: 1744995
    [Abstract] [Full Text] [Related]

  • 19. Protective effects of AE0047, a novel calcium antagonist, on incidence of stroke and hemodynamic disturbances in stroke-prone spontaneously hypertensive rats.
    Shinyama H, Nagai H, Kawamura T, Narita Y, Uchida T, Watanabe M, Kagitani Y.
    J Pharmacol Exp Ther; 1995 Feb 02; 272(2):911-9. PubMed ID: 7853209
    [Abstract] [Full Text] [Related]

  • 20. Effects of nilvadipine (a dihydropyridine-type calcium entry blocker) on cerebral blood flow in acute experimental brain ischemia in rats.
    Tanaka R, Miyasaka Y, Maruyama S, Nagai S, Fujii K.
    Neurol Res; 1996 Aug 02; 18(4):325-8. PubMed ID: 8875450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.